C. James

发表

Adefovir dipivoxil therapy for lamivudine‐resistant hepatitis B in pre– and post–liver transplantation patients

M. Wulfsohn, E. Schiff, J. Villeneuve, 2003, Hepatology.

BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.

Stephen B. Fox, S. Prakash, K. Shannon, 2021, Pathology.

Adefovir dipivoxil (ADV) for the treatment of lamivudine resistant HBV (LAM-R) in post liver transplant (post-OLT) patients

E. Schiff, D. Samuel, N. Terrault, 2002 .

Serum HBV DNA suppression and seroconversion following long-term adefovir dipivoxil therapy in chronic hepatitis B patients.

M. Sherman, T. Wright, E. Heathcote, 2001 .

46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)

P. Marcellin, S. Lim, M. Rizzetto, 2004 .

Baseline alt predicts histologic and serologic response in patients with HBeAg+ chronic hepatitis B treated with adefovir dipivoxil (ADV)

P. Marcellin, Z. Goodman, S. Lim, 2002 .

Sustained antiviral response and lack of viral resistance with long term adefovir dipivoxil (ADV) therapy in chronic HBV infection

M. Sherman, T. Wright, E. Heathcote, 2002 .

424 Durability of HBEAG seroconversion after adefovir dipivoxil treatment for chronic hepatitis B (CHB)

P. Marcellin, Y. Liaw, M. Shiffman, 2004 .

Original Articles: Viral HepatitisAdefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre– and post–liver transplantation patients☆

M. Wulfsohn, E. Schiff, J. Villeneuve, 2003 .

11 Adefovir dipivoxil 10 MG (ADV) for the treatment of chronic hepatitis B in patients pre-liver transplantation with lamivudine-resistant patients

N. Terrault, P. Neuhaus, H. Tillmann, 2003 .

1159 Lack of ethnic differences in response to adefovir dipivoxil therapy in HBEAG+ and HBEAG- patients with chronic hepatitis B

P. Marcellin, S. Lim, Ting Chang, 2003 .